ToolGen Incorporated (199800.KQ)
- Previous Close
36,850.00 - Open
36,850.00 - Bid 36,850.00 x --
- Ask 37,000.00 x --
- Day's Range
36,500.00 - 37,550.00 - 52 Week Range
28,500.00 - 89,900.00 - Volume
6,741 - Avg. Volume
20,757 - Market Cap (intraday)
292.351B - Beta (5Y Monthly) 1.89
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
www.toolgen.comRecent News: 199800.KQ
View MorePerformance Overview: 199800.KQ
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 199800.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 199800.KQ
View MoreValuation Measures
Market Cap
292.75B
Enterprise Value
257.81B
Trailing P/E
47.49
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
332.15
Price/Book (mrq)
5.01
Enterprise Value/Revenue
289.36
Enterprise Value/EBITDA
24.21
Financial Highlights
Profitability and Income Statement
Profit Margin
699.45%
Return on Assets (ttm)
-16.13%
Return on Equity (ttm)
14.08%
Revenue (ttm)
890.96M
Net Income Avi to Common (ttm)
6.23B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
48.96B
Total Debt/Equity (mrq)
23.98%
Levered Free Cash Flow (ttm)
-13.68B